ReviewViruses2022

Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience.

Karolina Akinosoglou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.